Relationship between endogenous testosterone and cardiovascular risk in early postmenopausal women

Metabolism: Clinical and Experimental

Volumn 57, Issue 7, 2008, Pages 961-965

  Maturana, Maria Augusta ^a   Breda, Vitor ^a,b   Lhullier, Francisco ^c   Spritzer, Poli Mara ^a,b  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; ENDOTHELIN 1; FIBRINOGEN; SEX HORMONE BINDING PROTEIN; TESTOSTERONE;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; WAIST CIRCUMFERENCE;

ANTHROPOMETRY; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHOLESTEROL; CROSS-SECTIONAL STUDIES; ENDOTHELIN-1; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; LUTEINIZING HORMONE; MIDDLE AGED; POSTMENOPAUSE; RISK; TESTOSTERONE; TRIGLYCERIDES; WAIST-HIP RATIO;

EID: 44949094572     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2008.02.012     Document Type: Article

References (32)

1. American Heart Association. Heart disease and stroke statistics-2003 update (2002), American Heart Association, Dallas
2. Anderson T. Assessment and treatment of endothelial dysfunction in humans. JACC 34 (1999) 631-638
3. Thorand B., Baumert J., Chambless L., Meisinger C., Kobb H., Doring A., et al., For the MONICA/KORA study group. Elevated markers of endothelial dysfunction predict type 2 diabetes mellitus in middle-aged men and women from the general population. Arterioscler Thromb Vasc Biol 26 (2006) 398-405
4. Taddei S., Ghiadoni L., Virdis A., Versari D., and Salvetti A. Mechanisms of endothelial dysfunction: clinical significance and preventive non-pharmacological therapeutic strategies. Curr Pharm Des 9 (2003) 2385-2402
5. Gokce N., Vita J.A., McDonnell M., Forse A.R., Istfan N., Stoeckl M., et al. Effect of medical and surgical weight loss on endothelial vasomotor function in obese patients. Am J Cardiol 95 (2005) 266-268
6. Sakkinen P., Abbott R.D., Curb J.D., Rodriguez B.L., Yano K., and Tracy R.P. C-reactive protein and myocardial infarction. J Clin Epidemiol 55 (2002) 445-451
7. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N England J Med 342 (2000) 836-843
8. Ridker P.M., Buring J.E., Shih J., Matias M., and Hennekens C.H. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 98 (1998) 731-733
9. Kim J., Montagnani M., Koh K.K., and Quon M.J. Reciprocal relationships between insulin resistance and endothelial dysfunction. Circulation 113 (2006) 1888-1904
10. Diamanti-Kandarakis E., Spina G., Kouli C., and Migdalis I. Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy. J Clin Endocrinol Metab 86 (2001) 4666-4673
11. Silvestri A., Gambacciani M., Vitale C., Monteleone P., Ciaponi M., Fini M., et al. Different effect of hormone replacement therapy, DHEAS and tibolone on endothelial function in postmenopausal women with increased cardiovascular risk. Maturitas 50 (2005) 305-311
12. Polderman K.H., Stehouwer C.D.A., van Kamp G.J., Dekker G.A., Verheugt W.A., and Gooren L.J.G. Influence of sex hormones on plasma endothelin levels. Ann Intern Med 118 (1993) 429-432
13. Toscani M.K., Migliavacca R., Sisson de Castro J.A., and Spritzer P.M. Estimation of truncal adiposity using waist circumference or the sum of trunk skinfolds: a pilot study for insulin resistance screening in hirsute patients with or without polycystic ovary syndrome. Metabolism 56 (2007) 992-997
14. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Ivo Jr. J.L., et al. The JNC 7 report (the seventh report of joint national committee on prevention detection, detection, evaluation, and treatment of high blood pressure) and the national high blood pressure education program coordinating committee. JAMA 289 (2003) 2560-2572
15. Katz A., Nambi S.S., Mather K., Baron A.D., Follmann D.A., Sullivan G., et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85 (2000) 2402-2410
16. Frajndlich R., and Spritzer P.M. Association between ovarian volume and serum insulin levels in ovulatory patients with idiopathic hirsutism. Fertil Steril 831 (2005) 561-564
17. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
18. Wiltgen D., Furtado L., Kohek M.B.F., and Spritzer P.M. CAPN10 UCSNP-43, UCSNP-19 and UCSNP-63 polymorphisms and metabolic syndrome in polycystic ovary syndrome (PCOS). Gynecol Endocrinol 23 (2007) 173-178
19. Webb C.M., Gathei M.A., Mc Neill J.G., and Collins P. 17beta-estradiol decreases endothelin-1 levels in the coronary circulation of postmenopausal women with coronary artery disease. Circulation 102 (2000) 1617-1622
20. Orio Jr. F., Palomba S., Spinelli L., Cascella T., Tauchmanova L., Zullo F., et al. The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study. J Clin Endocrinol Metab 89 (2004) 3696-3701
21. Orio F.J., Palomba S., Cascella T., De Simone B., Manguso F., Savastano S., et al. Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month study. J Endocrinol Metab 90 (2005) 6072-6076
22. Meigs J.B., Mittleman M.A., Nathan D.M., et al. Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. JAMA 283 (2000) 221-228
23. Sutton-Tyrrell K., Wildman R.P., Matthews K.A., Chae C., Lasley B.L., Brockwell S., et al., for the SWAN Investigators. Sex hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the study of women across the nation (SWAN). Circulation 111 (2005) 1242-1249
24. Sowers M.R., Jannausch M., Randolph J.F., McConnell D., Little R., Lasley B., et al. Androgens are associated with hemostatic and inflammatory factors among women at the mid-life. J Clin Endocrinol Metab 90 (2005) 6064-6071
25. Folsom A.R., Golden S.H., Boland L.L., and Szklo M. Association of endogenous hormones with C-reactive protein, fibrinogen, and white blood count in post-menopausal women. Eur J Epidemiol 20 (2005) 1015-1022
26. Nacul A.P., Andrade C.D., Schwarz P., Homem de Bittencourt Jr. P.I., and Spritzer A.P. Nitric oxide and fibrinogen in polycystic ovary syndrome: associations with insulin resistance and obesity. Eur J Obst Gynecol Reprod Biol 133 (2007) 191-196
27. Pripp U., Eriksson-Berg M., Orth-Gomer K., Schenck-Gustafsson K., and Landgren B.M. Does body mass index, smoking, lipoprotein levels, surgically induced menopause, hormone replacement therapy, years since menopause, or age affect hemostasis in postmenopausal women?. Gend Med 2 (2005) 88-95
28. Danesh J., Whincup P., Walker M., Lennon L., Thomson A., Appleby P., et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 321 (2000) 199-204
29. Crandall C., Palla S., Reboussin B., Hu P., Barrett-Connor E., Reuben D., et al. Cross-sectional association between markers of inflammation and serum sex steroid levels in the postmenopausal estrogen/progestin interventions trial. J Women's Health 15 (2006) 14-23
30. Kaczmarek A., Reczuch K., Majda J., Banasiak W., and Ponikowski P. The association of lower testosterone level with coronary artery disease in postmenopausal women. Int J Cardiol 87 (2003) 53-57
31. Joffe H.V., Ridcker P.M., Manson N.R., Buring J.E., and Rexrode K.M. Sex hormone-binding globulin and serum testosterone are inversely associated with C-reactive protein levels in postmenopausal women at high risk for cardiovascular disease. Ann Epidemiol 16 (2006) 105-112
32. Maturana M.A., and Spritzer P.M. Association between hyperinsulinemia and endogenous androgen levels in peri- and postmenopausal women. Metabolism 51 (2002) 238-243